JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M403042200 on April 9, 2004

J. Biol. Chem., Vol. 279, Issue 26, 27790-27798, June 25, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/26/27790    most recent
M403042200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zou, Y.
Right arrow Articles by Friedman, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zou, Y.
Right arrow Articles by Friedman, E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Mirk/dyrk1B Kinase Destabilizes Cyclin D1 by Phosphorylation at Threonine 288*

Yonglong Zou, Daina Z. Ewton, Xiaobing Deng, Stephen E. Mercer, and Eileen Friedman{ddagger}

From the Department of Pathology, Upstate Medical University, Syracuse, New York 13210

The phosphorylation of cyclin D1 at threonine 286 by glycogen synthase kinase 3{beta} (GSK3{beta}) has been shown to be required for the ubiquitination and nuclear export of cyclin D1 and its subsequent degradation in the proteasome. The mutation of the nearby residue, threonine 288, to nonphosphorylatable alanine has also been shown to reduce the ubiquitination of cyclin D1, suggesting that phosphorylation at threonine 288 may also lead to degradation of cyclin D1. We now demonstrate that the G0/G1-active arginine-directed protein kinase Mirk/dyrk1B binds to cyclin D1 and phosphorylates cyclin D1 at threonine 288 in vivo and that the cyclin D1-T288A construct is more stable than wild-type cyclin D1. Transient overexpression of Mirk in nontransformed Mv1Lu lung epithelial cells blocked cells in G0/G1. Depletion of endogenous Mirk by RNA interference increased cyclin D1 protein levels but not mRNA levels, indicating that Mirk destabilizes cyclin D1 protein. Destabilization was confirmed by induction of a stable Mirk transfectant of Mv1Lu cells, which blocked cell migration (Zou, Y., Lim, S., Lee, K., Deng, X., and Friedman, E. (2003) J. Biol. Chem. 278, 49573-49581), and caused a decrease in the half-life of endogenous cyclin D1, concomitant with an increase in Mirk expression. In vitro cyclin D1 was phosphorylated in an additive fashion by Mirk and GSK3{beta}. Mirk-phosphorylated cyclin D1 mutated at the GSK3{beta} phosphorylation site and was capable of phosphorylating cyclin D1 in the presence of the GSK3{beta} inhibitor LiCl. Mirk may function together with GSK3{beta} to assist cell arrest in G0/G1 by destabilizing cyclin D1.


Received for publication, March 18, 2004

* This work was supported by Public Health Service Award RO1 CA67405 (to E. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} To whom correspondence should be addressed: Dept. of Pathology, Upstate Medical University, 2303 Weiskotten Hall, 750 E. Adams St., Syracuse, NY 13210. Tel.: 315-464-7138; Fax: 315-464-8419; E-mail: friedmae{at}upstate.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
S. G. Menon, E. H. Sarsour, A. L. Kalen, S. Venkataraman, M. J. Hitchler, F. E. Domann, L. W. Oberley, and P. C. Goswami
Superoxide Signaling Mediates N-acetyl-L-cysteine-Induced G1 Arrest: Regulatory Role of Cyclin D1 and Manganese Superoxide Dismutase
Cancer Res., July 1, 2007; 67(13): 6392 - 6399.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Nurtjahja-Tjendraputra, D. Fu, J. M. Phang, and D. R. Richardson
Iron chelation regulates cyclin D1 expression via the proteasome: a link to iron deficiency-mediated growth suppression
Blood, May 1, 2007; 109(9): 4045 - 4054.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Takahashi-Yanaga, J. Mori, E. Matsuzaki, Y. Watanabe, M. Hirata, Y. Miwa, S. Morimoto, and T. Sasaguri
Involvement of GSK-3beta and DYRK1B in Differentiation-inducing Factor-3-induced Phosphorylation of Cyclin D1 in HeLa Cells
J. Biol. Chem., December 15, 2006; 281(50): 38489 - 38497.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
P. Fasanaro, A. Magenta, G. Zaccagnini, L. Cicchillitti, S. Fucile, F. Eusebi, P. Biglioli, M. C. Capogrossi, and F. Martelli
Cyclin D1 degradation enhances endothelial cell survival upon oxidative stress
FASEB J, June 1, 2006; 20(8): 1242 - 1244.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. E. Mercer, D. Z. Ewton, S. Shah, A. Naqvi, and E. Friedman
Mirk/Dyrk1b mediates cell survival in rhabdomyosarcomas.
Cancer Res., May 15, 2006; 66(10): 5143 - 5150.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Deng, D. Z. Ewton, S. Li, A. Naqvi, S. E. Mercer, S. Landas, and E. Friedman
The Kinase Mirk/Dyrk1B Mediates Cell Survival in Pancreatic Ductal Adenocarcinoma.
Cancer Res., April 15, 2006; 66(8): 4149 - 4158.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-T. Kwak, R. Li, C. R. Becerra, D. Tripathy, E. P. Frenkel, and U. N. Verma
I{kappa}B Kinase {alpha} Regulates Subcellular Distribution and Turnover of Cyclin D1 by Phosphorylation
J. Biol. Chem., October 7, 2005; 280(40): 33945 - 33952.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Ma, Q. Feng, D. Sekula, J. A. Diehl, S. J. Freemantle, and E. Dmitrovsky
Retinoid Targeting of Different D-Type Cyclins through Distinct Chemopreventive Mechanisms
Cancer Res., July 15, 2005; 65(14): 6476 - 6483.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. E. Mercer, D. Z. Ewton, X. Deng, S. Lim, T. R. Mazur, and E. Friedman
Mirk/Dyrk1B Mediates Survival during the Differentiation of C2C12 Myoblasts
J. Biol. Chem., July 8, 2005; 280(27): 25788 - 25801.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Deng, D. Z. Ewton, S. E. Mercer, and E. Friedman
Mirk/dyrk1B Decreases the Nuclear Accumulation of Class II Histone Deacetylases during Skeletal Muscle Differentiation
J. Biol. Chem., February 11, 2005; 280(6): 4894 - 4905.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. Skildum, E. Faivre, and C. A. Lange
Progesterone Receptors Induce Cell Cycle Progression via Activation of Mitogen-Activated Protein Kinases
Mol. Endocrinol., February 1, 2005; 19(2): 327 - 339.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.